Clinical Trials on SARS Pneumonia

Total 10325 results

Ministry of Health, Turkey
Istanbul University; Ankara Training and Research Hospital; Prof. Dr. Cemil Tascıoglu... and other collaborators

Active, not recruiting

Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19

COVID-19 | Sars-CoV2

Turkey
MELISA Institute Genomics & Proteomics Research...
Universidad Austral

Unknown

Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers (HERD)

COVID-19 | SARS-CoV2
Centre Hospitalier Universitaire de Saint Etienne
CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang

Terminated

Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients (PREAVIS)

Sars-CoV2

France
Christoph Berger

Not yet recruiting

A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study (MYTHIC)

Community Acquired Pneumonia in Children | Mycoplasma Pneumoniae | Mycoplasma Pneumoniae Pneumonia

Switzerland
Hegau-Bodensee-Klinikum Singen

Completed

Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial (SubFSC19-KN)

SARS-CoV2 Infection

Germany
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
University Hospital, Tours

Recruiting

Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients (Long-termAPP)

SARS-CoV 2 Pneumonia

France
The Scientific and Technological Research Council...
Koç University; Ankara City Hospital Bilkent; Monitor CRO; Istanbul Umraniye Training...

Not yet recruiting

Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19 (COVID-19)

COVID-19 | SARS-CoV2

Turkey
Bryan Burt, MD
Brigham and Women's Hospital

Completed

Cyclosporine For The Treatment Of COVID-19(+)

SARS (Disease)

United States
Nantes University Hospital
Xenothera SAS; BPIfrance

Completed

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia (POLYCOR)

SARS Virus

France, Martinique, Réunion
Assistance Publique - Hôpitaux de Paris

Completed

Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients (NICOVID)

SARS-COV2

France
University of Wisconsin, Madison
National Institutes of Health (NIH); AIDS Vaccine Research Lab

Completed

Rapid, Onsite COVID-19 Detection

COVID-19 | Sars-CoV2

United States
Northwell Health

Completed

Incidence of COVID-19 Test Conversion in Post-surgical Patients

Sars-CoV2

United States
George Sakoulas, MD
Octapharma

Completed

Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

Sars-CoV2

United States
Hospital de Clinicas de Porto Alegre

Unknown

Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19 (COVID19)

COVID-19 | Sars-CoV2
University Hospital, Strasbourg, France

Unknown

Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic (COVID-PRONE)

Sars-CoV2

France
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Completed

Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells

Pneumonia, Viral | Pneumonia | Covid-19 | COVID | Coronavirus | Sars-CoV2 | Pneumonia, Interstitial

Belarus
I.M. Sechenov First Moscow State Medical University

Completed

Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure (COVID-VENT)

SARS Pneumonia

Russian Federation
University of Pittsburgh

Completed

Etiology of Community Acquired Pneumonia (CAP)

Streptococcus Pneumonia | Mycoplasma Pneumonia | Haemophilus Influencae | Chlamydia Pneumonia

United States
EDAN Instruments Inc.
MDx CRO (MED IVD HEALTHTECH S.L.)

Recruiting

Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory Infection

SARS-CoV2 Infection | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

Spain
Maimónides Biomedical Research Institute of Córdoba
Dynamic Solutions; Faes Farma, S.A.; Junta de Andalucía - Consejería de Salud...

Completed

Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome (COVIDIOL)

SARS-CoV 2 | COVID19 | Cytokine Storm | Cytokine Release Syndrome | SARS (Severe Acute Respiratory Syndrome)

Spain
Fayoum University

Completed

Oral Manifestation in Patients With SARS-CoV2 Infection.

SARS-CoV Infection

Egypt
ProgenaBiome
Topelia Therapeutics

Active, not recruiting

Trial of Combination Therapy to Treat COVID-19 Infection

Coronavirus Infection | Covid-19 | COVID | Corona Virus Infection | SARS-CoV Infection | SARS-CoV2 | Coronavirus-19

United States
BioAegis Therapeutics Inc.

Completed

Rhu-pGSN for Severe Covid-19 Pneumonia

Sars-CoV2

Romania, Spain
Priscilla Hsue, MD
San Francisco General Hospital; Blood Systems Research Institute

Completed

Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients (CAPRI)

COVID-19 | Sars-CoV2

United States
Stanford University

Completed

Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19

COVID-19 | Sars-CoV2

United States
University of Milano Bicocca

Completed

The Prone Position in Covid-19 Affected Patients (PRON-COVID)

Sars-CoV2

Italy
SAb Biotherapeutics, Inc.
Biomedical Advanced Research and Development Authority; Joint Program Executive...

Active, not recruiting

Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19

COVID-19 | SARS-CoV2

United States
Federal Research Clinical Center of Federal Medical...

Completed

Clinical Features of Severe Patients With COVID-19

SARS-CoV2

Russian Federation
Sara Ghandehari
IBSA Institut Biochimique SA

Completed

Progesterone for the Treatment of COVID-19 in Hospitalized Men

COVID-19 | Sars-CoV2

United States
University Hospital, Strasbourg, France

Unknown

Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation (TubeObs-Covid)

Sars-CoV2

France
University Hospital, Montpellier
Société espagnole de pneumologie (SEPAR); Societe française de kinésithérapie...

Unknown

Implementation of Physiotherapy on COVID-19 Patients in ICU (PHYSIO-COVID)

COVID-19 | Sars-CoV2

France
University Children's Hospital, Zurich
University Children's Hospital Basel; Ostschweizer Kinderspital

Unknown

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy (myKIDS-STEP)

Community-acquired Pneumonia

Switzerland
Davita Clinical Research

Completed

COVID-19 Progression in End-Stage Kidney Disease (COPE)

SARS-CoV-2 Infection (Asymptomatic) | SARS-CoV-2 Infection (Symptomatic)

United States
University of Chicago

Recruiting

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection (COVID-19)

COVID-19

United States
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Direction Centrale du Service de Santé des Armées

Recruiting

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics (COVOICE)

COVID-19 | Sars-CoV-2 Infection

France
Bioxytran Inc.

Not yet recruiting

To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M

COVID-19 | SARS CoV 2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Centre Hospitalier Régional d'Orléans

Recruiting

Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum Antibodies (PNAS)

COVID-19 | SARS CoV 2 Infection

France
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Federal University of Espirito Santo
Instituto René Rachou/Fiocruz; Escola Nacional de Saúde Pública Sérgio Arouca... and other collaborators

Recruiting

EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

SARS-CoV-2

Brazil
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
ARCTEC
Cardiff University; Durham University; Medical Detection Dogs

Recruiting

Canine COVID-19 Detection Phase 2 and 3 (LSH1394)

Covid19 | SARS-CoV2 Infection

United Kingdom
Sinocelltech Ltd.

Not yet recruiting

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19 (MAOP3)

COVID-19 | SARS-CoV-2
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France

Not yet recruiting

Myeloid Cells in Patients With Covid-19 Pneumonia (MyeloidCovid)

Covid-19; SARS-Cov2
University of Zurich
Swiss School of Public Health (SSPH+)

Recruiting

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children (CiaoCorona)

COVID-19 | SARS-CoV 2

Switzerland
Assistance Publique - Hôpitaux de Paris

Recruiting

Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 (DEXDO-COVID)

SARS-CoV 2

France
Instituto de Investigación Marqués de Valdecilla
Hospital Universitario de Canarias; Hospital Universitario Marqués de Valdecilla and other collaborators

Recruiting

Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry (RegCOVID19)

SARS-CoV-2

Spain
Invivyd, Inc.

Active, not recruiting

A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2

COVID-19 | SARS-CoV-2

United States

Clinical Trials on SARS Pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations